跳至主要内容
临床试验/NCT03220971
NCT03220971Unknown不适用

Theranostic Translation Applications Against Viral, Metabolic Liver Diseases and Hepatic Oncogenesis: Lipoprotein and Apolipoproteins at a Crossroad

Chun-Hsiang Wang1 个研究点 分布在 1 个国家目标入组 440 人开始时间: 2017年9月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
440
试验地点
1
主要终点
Theranostic Translation Applications Against Viral, Metabolic Liver Diseases and Hepatic Oncogenesis: Lipoprotein and Apolipoproteins at a Crossroad

研究概览

简要总结

Theranostic translation applications against viral, metabolic liver diseases and hepatic oncogenesis: lipoprotein and apolipoproteins at a crossroad

详细描述

An intimate link between microbial infections, metabolic changes and oncogenesis has been drawn attentions increasingly, indicating a crossroad leading to pathogenesis and disease progression. Globally the burden of hepatitis B and C virus infections is 450 and 185 millions, respectively and chronic hepatitis disease causes a high risk of liver cirrhosis, hepatocellular carcinoma and metabolic disorders

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • above 20 years
  • nonalcoholic fatty liver disease
  • Non-Alcoholic Steatohepatitis

排除标准

  • alcohonic hepatitis
  • Autoimmune liver disease
  • HIV postive

结局指标

主要结局

Theranostic Translation Applications Against Viral, Metabolic Liver Diseases and Hepatic Oncogenesis: Lipoprotein and Apolipoproteins at a Crossroad

时间窗: 2years

Study the interplay between hepatitis C virus (HCV) and lipid metabolism(the HCV infection affects host lipid homeostasis, regarding transportation, synthesis, and catabolism.)

次要结局

未报告次要终点

研究者

发起方
Chun-Hsiang Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chun-Hsiang Wang

Tainan Municipal Hospital

Tainan Municipal Hospital

研究点 (1)

Loading locations...

相似试验